Earnings call transcript: ELF Beauty Q1 2025 sees 9% sales growth

ELF Beauty Inc. (ELF) reported robust Q1 FY26 results with net sales up 9% year-over-year to $354 million and EPS of $0.89, surpassing analyst forecasts despite a slight revenue miss. The company extended its streak of market share gains to 26 consecutive quarters, fueled by a 30% surge in international sales. Strategically, ELF completed the $800 million acquisition of Rhode skincare post-quarter and is expanding into new retail channels, signaling aggressive growth plans. While gross margins faced pressure from tariffs, leading to a recent price increase, investor confidence was reflected in a modest 0.5% aftermarket stock increase, underscoring the company's continued growth trajectory despite ongoing tariff uncertainties.

Analysis

ELF Beauty Inc. reported a solid Q1 FY26, characterized by resilient growth and strategic expansion, albeit overshadowed by significant tariff-related headwinds. Net sales grew 9% year-over-year to $354 million, driven by exceptional 30% growth in international markets, while the company continued its impressive domestic market share gains for the 26th consecutive quarter. The reported EPS of $0.89 beat forecasts by 5.95%, demonstrating strong profitability. However, gross margin contracted by 215 basis points to 69% due to tariff costs, a pressure point management expects to intensify in Q2 as higher-cost inventory flows through. To mitigate the estimated $50 million annualized impact from tariffs, the company implemented a $1 price increase across its portfolio. The most significant strategic development is the recent $800 million acquisition of Rhode, a high-growth skincare brand, which is expected to bolster top-line growth and accelerate the company's expansion into new retail channels like Sephora. While management guides for above 9% sales growth and a 20% adjusted EBITDA margin for the first half, the lack of full-year guidance underscores the material uncertainty surrounding future tariff rates.

Key Decisions for Investors

• Investors should weigh the company's strong organic growth and market share momentum against the significant near-term risk of gross margin compression from tariff uncertainty.
• The successful integration of the newly acquired Rhode skincare brand and its upcoming launch in Sephora is a key catalyst that could significantly accelerate revenue growth and should be monitored closely.
• Pay close attention to consumer elasticity in response to the recent $1 price increase, as its effectiveness in offsetting tariff costs will be a critical determinant of future profitability.
• Given the absence of full-year guidance, it is prudent to await clarity on the tariff situation and subsequent management outlook before making significant adjustments to positions, as this will be a major stock-rerating event.